Overall our findings suggest that FAAH inhibitors may be a viable approach for the treatment of stress-related neuropsychiatric disorders and PTSD in particular and that these therapeutic effects are mediated via a β-catenin-dependent mechanism. Here, FAAH is linked to post-traumatic stress disorder.